Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study

Stéfano Kim, François Ghiringhelli, Christelle de la Fouchardière, Ludovic Evesque, Denis Smith, Nicolas Badet, Emmanuelle Samalin, Daniel Lopez-Trabada Ataz, Aurélie Parzy, Jérôme Desrame, Nabil Baba Hamed, Bruno Buecher, David Tougeron, Olivier Bouché, Laëtitia Dahan, Benoist Chibaudel, Farid El Hajbi, Laurent Mineur, Olivier Dubreuil, Méher Ben Abdelghani, Solange Pécout, Frédéric Bibeau, Michaël Herfs, Marie‐Line Garcia, Aurélia Meurisse, Déwi Vernerey, Julien Taı̈eb, Christophe Borg